CoChat
Sign Up
Cited by 158Health Systems, Economic Evaluations, Quality of LifeDiabetes Management and EducationDiabetes Treatment and Management

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Coping with Type II diabetes: the patient’s perspective

Open access
Koopmanschap, M.·2002·Diabetologia
DOI 10.1007/s00125-002-0861-2
Open this paper in CoChat — free accountOpen PDF

Abstract

Aims/hypothesis The Cost of Diabetes in Europe-Type II study is the first coordinated attempt to assess the total costs of Type II (non-insulin-dependent) diabetes mellitus in Europe. Although gaining a clearer understanding of the economics of diabetes was the goal of the study, a secondary objective was to consider the impact of Type II diabetes from the patient's perspective.Methods The protocol included a health status questionnaire completed by the patient, the EQ-5D instrument, which assessed health-related quality of life by asking the patient to consider five dimensions: mobility, self-care, usual activities, pain and discomfort, as well as anxiety and depression.Results A total of 4189 patients in five of the eight countries completed the EQ-5D questionnaire for assessing the quality of life. Overall, patients with Type II diabetes reported scores between good and fair states of health, although the average score (0.69) was lower than that of the similarly aged, healthy population in the United Kingdom. However, these values were higher (0.76) in Type II diabetic patients without complications. The onset of either microvascular or macrovascular complications adversely affected quality of life (0.69 and 0.69, respectively), and the presence of both types of complications further reduced the quality of life score to 0.59. Treatment with insulin was also associated with a reduced quality of life (0.62). Multivariate analysis showed that the following factors, in order of importance, independently pre-dict a poorer quality of life: gender, complications, treatment type, age, obesity and hyperglycaemia.Conclusion/interpretation The results showed that health-related quality of life is an important issue in Type II diabetes and this decreases with disease progression. The implication for policy-makers is that reducing or preventing the complications of diabetes is the key to improving patient quality of life.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-002-0861-2

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Research works printed but not linked: 4

  1. Drummond MF, O’Brien B, Stoddart GL, Torrance GW (1997) Methods for the Economic Evaluation of Healthcare Programmes, 2nd edn. Oxford University Press, Oxford
  2. Jonsson B (2000) Revealing the cost of Type 2 diabetes in Europe. Diabetologia supplement (this issue)
  3. World Health Organisation (1948) World Health Organisation constitution. In: Basic Documents. World Health Organisation, Geneva New Eng J Med 334(13):835–840
  4. Cunha-Vaz J (1998) Lowering the risk of visual impairment and blindness. 15:S47–S50

Cited by

Sorted by citations

Related

See all

Metadata

Authors
Koopmanschap, M.
Affiliations
Erasmus University Rotterdam (NL)
Corresponding author
Koopmanschap, M.
Venue
Diabetologia
Publisher
Springer Science and Business Media LLC
Published
2002-05-24
Volume
45
Issue
S1
Pages
S21-S22
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
DOI
10.1007/s00125-002-0861-2
OpenAlex
W1984692300
Cited by
158
References
19
Citations by year
2025: 2 · 2024: 5 · 2023: 3 · 2022: 5 · 2021: 7 · 2020: 9 · 2019: 6 · 2018: 11 · 2017: 6 · 2016: 9 · 2015: 9 · 2014: 6 · 2013: 3 · 2012: 7
FWCI
15.35
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Diabetologia (publishedVersion)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
type 2 diabetes, health-related quality of life, EQ-5D, diabetes complications, microvascular complications, macrovascular complications, insulin therapy, patient perspectives, obesity, hyperglycemia, disease progression
MeSH terms
Adaptation, Psychological, Analysis of Variance, Attitude to Health, Costs and Cost Analysis, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Europe, Health Status, Humans, Quality of Life, Surveys and Questionnaires

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review